Table 3 Complications and adverse events rates in both groups
Group D (DEX) | Group C (control) | Odds ratio (CI 95 %) | p value | |
|---|---|---|---|---|
Adverse events | ||||
Hypotension, n (%) | 8/35 (23) | 4/32 (13) | 2 (0.48–11) | 0.34 |
Hypertension, n (%) | 0/35 | 4/32 (16) | 11 (0.6–190) | 0.05 |
Tachycardia, n (%) | 0/35 | 5/32 (16) | 14 (0.9–283) | 0.02 |
Bradycardia, n (%) | 10/35 (31) | 2/32 (6) | 6 (1.3–73) | 0.03 |
Desaturation, n (%) | 1/35 (3) | 5/32 (15) | 5.3 (0.6–280) | 0.2 |
Hypoglycemia, n (%) | 2/35 (6) | 1/32 (3) | 2 (0–114) | 1.0 |
Hyperglycemia, n (%) | 5/35 (14) | 9/32 (28) | 2 (0.7–9) | 0.2 |
Complications | ||||
Hospital pneumonia, n (%) | 1/35 (3) | 2/32 (6) | 2 (0.1–125) | 0.6 |